MEETINGS - Conference entitled Funding and reimbursement for medical technology - the latest on the European market (Belgium) April 2001:
This article was originally published in Clinica
IBC conferences in the UK will hold a conference entitled Funding and reimbursement for medical technology - the latest on the European market in Brussels, Belgium, on April 3. The meeting will address funding and reimbursement trends across Europe and future challenges of healthcare financing; and the EUCOMED position paper on health technology assessment for medical devices. Clinica's Amanda Maxwell will chair the afternoon panel discussion. For more information contact IBC conferences in the UK. Tel: +44 (0) 20 7453 5492. Fax: +44 (0) 20 7636 6858. Email: firstname.lastname@example.org www.healthcare-info.co.uk/reimbursement
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.